Literature DB >> 6786845

Colonic inhibition of gastric secretion in man.

R Jian, H S Besterman, D L Sarson, C Aymes, J Hostein, S R Bloom, J C Rambaud.   

Abstract

The effect of colonic infusion of various solutions on submaximal pentagastrin-stimulated gastric secretion was determined in healthy volunteers. Hypertonic (823 mOsm/kg) glucose, mannitol, and saline, and also isotonic glucose significantly induced a marked and sustained inhibition of gastric acid secretion of 74%, 66%, 79%, and 54%, respectively. A similar degree of inhibition was obtained for pepsin secretion with hypertonic glucose and mannitol. Isotonic triglycerides and isotonic saline solutions had no significant effect on gastric acid secretion. Hypertonic glucose, mannitol, and saline infusions significantly increased plasma concentrations of enteroglucagon, whereas other solutions had no effect. No correlation, however, was found between the percentage rise of enteroglucagon and the percentage inhibition of gastric secretion obtained from any of the three hypertonic solutions. The physiological significance of these findings remains to be established.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786845     DOI: 10.1007/BF01391629

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Identification of cells with pancreatic-type and gut-type glucagon immunoreactivity in the human colon.

Authors:  J B Knudsen; J J Holst; S Asnaes; A Johansen
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11

2.  Measurement of human plasma motilin.

Authors:  S R Bloom; P Mitznegg; M G Bryant
Journal:  Scand J Gastroenterol Suppl       Date:  1976

3.  Fine structural classification and comparative distribution of endocrine cells in normal human large intestine.

Authors:  M L Cristina; T Lehy; P Zeitoun; F Dufougeray
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

Review 4.  The newer gut hormones. Cellular sources, physiology, pathology, and clinical aspects.

Authors:  A G Pearse; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

5.  [Value of a multicenter cooperative study for the establishment of a table of normal values for gastric acid secretion in relation to sex, age and body weight].

Authors:  J J Bernier; N Vidon; M Mignon
Journal:  Biol Gastroenterol (Paris)       Date:  1973

6.  The effect of prostaglandin E 1 on the pentagastrin-stimulated gastric secretion in man.

Authors:  M Classen; H Koch; J Bickhardt; G Topf; L Demling
Journal:  Digestion       Date:  1971       Impact factor: 3.216

7.  Role of gastrointestinal hormones in the response to massive resection of the small bowel.

Authors:  A A D'sa; K D Buchanan
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

8.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

9.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.

Authors:  R H Unger; A Ohneda; I Valverde; A M Eisentraut; J Exton
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

10.  Pancreotone, an inhibitor of pancreatic secretion in extracts of ileal and colonic mucosa.

Authors:  A A Harper; A J Hood; J Mushens; J R Smy
Journal:  J Physiol       Date:  1979-07       Impact factor: 5.182

View more
  10 in total

1.  Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog.

Authors:  T Hashimoto; F Lluis; G Gomez; F L Hill; G H Greeley; J C Thompson
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

3.  Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides.

Authors:  T E Adrian; E M Quigley; S G Rose; T J Johnson; J S Thompson
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

4.  Effect of painless rectal distension on gastrointestinal transit of solid meal.

Authors:  M S Youle; N W Read
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

Review 5.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

6.  Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders.

Authors:  D M Preston; T E Adrian; N D Christofides; J E Lennard-Jones; S R Bloom
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

7.  Enterogastrone-like effect of peptide YY is vagally mediated in the dog.

Authors:  T N Pappas; H T Debas; I L Taylor
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.

Authors:  P Layer; J J Holst; D Grandt; H Goebell
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

9.  Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats.

Authors:  B M Miazza; M Y Al-Mukhtar; M Salmeron; M A Ghatei; M Felce-Dachez; A Filali; R Villet; N A Wright; S R Bloom; J C Crambaud
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

10.  Inhibitory effects of resistant starch (RS3) as a carrier for stachyose on dextran sulfate sodium-induced ulcerative colitis in C57BL/6 mice.

Authors:  Yu Qian; Xin Zhao; Jia-LE Song; Kai Zhu; Peng Sun; Gui-Jie Li; Rui Wang; Jian-Quan Kan
Journal:  Exp Ther Med       Date:  2013-09-02       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.